Support the Patients’ Access to Treatment Act (H.R. 460)
Performing simple tasks with a rheumatic disease can be impossible. Paying for treatment shouldn’t be.
Rheumatic diseases affect over 11 million Americans of all ages. For many, access to specific medication is the only way to prevent disability and ensure quality of life. These life-saving treatments are increasingly being moved to a more expensive ‘Fourth Tier,’ that can add between $12,000 and $48,000 in out of pocket costs to each patient’s treatment every year.
New study shows H.R. 460 would have negligible impact on insurance premiums.
- Read the Coalition For Accessible Treatment’s Press Release: PATA Study Findings
- View the full study, Final Press Release: Final PATA Study Findings
Learn more about the Patients Access to Treatment Act
If you are a lawmaker, discover ways you can support your constituents who are affected by rheumatic diseases – take action.